A New Method for Rapid Cytotoxic T-lymphocyte Induction Using a Multiple Cytokine Cocktail

被引:0
|
作者
Onishi, Hideya [2 ]
Koya, Norihiro
Kiyota, Akifumi
Tanaka, Hiroto
Umebayashi, Masayo
Katano, Mitsuo [2 ]
Morisaki, Takashi [1 ]
机构
[1] Fukuoka Canc Gen Clin, Hakata Ku, Fukuoka 8120018, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Canc Therapy & Res, Fukuoka 812, Japan
关键词
Cytotoxic T-lymphocytes; cytokine cocktail; dendritic cells; DENDRITIC CELLS; IMMUNIZATION; IMMUNITY; ANTIGEN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunotherapy using cytotoxic T-lymphocytes (CTLs) still has limited success. An increase in the frequency of CTL administration is one method to improve immunotherapy using CTLs. The conventional method (C-method) that generates CTLs after the induction of dendritic cells requires a long time period. If CTLs can be more rapidly and simply induced, the frequency of immunotherapy could be increased and unexpected contamination could be avoided. In this study, in order to more rapidly induce functional CTLs, we investigated a new method (N-method) that uses a cytokine cocktail, including interleukin (IL)-2, IL-4, granulocyte macrophage colony-stimulating factor, tumour necrosis factor-a and interferon-a, together with a tumour lysate. CTLs induced by the N-method had equivalent functions, such as proliferation, surface antigen expression and cytotoxicity, compared with those induced by the C-method. These results suggest that the N-method can substitute the C-method in order to improve the effect of immunotherapy using CTLs.
引用
收藏
页码:2385 / 2390
页数:6
相关论文
共 50 条
  • [41] CYTOKINE AND CYTOTOXIC T-LYMPHOCYTE (CTL) TRANSCRIPT LEVELS IN SURVEILLANCE RENAL-ALLOGRAFT BIOPSIES BY QUANTITATIVE PCR
    LIPMAN, M
    JEFFERY, J
    GOUGH, J
    MCKENNA, R
    GRIMM, P
    RUSH, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1060 - 1060
  • [42] Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning
    Morris, JC
    Conerly, M
    Thomasson, B
    Storek, J
    Riddell, SR
    Kiem, HP
    BLOOD, 2004, 103 (02) : 492 - 499
  • [43] OLIGOPEPTIDE INDUCTION OF A CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HER-2/NEU PROTOONCOGENE IN-VITRO
    FISK, B
    CHESAK, B
    POLLACK, MS
    WHARTON, JT
    IOANNIDES, CG
    CELLULAR IMMUNOLOGY, 1994, 157 (02) : 415 - 427
  • [44] Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
    Brossart, P
    Wirths, S
    Stuhler, G
    Reichardt, VL
    Kanz, L
    Brugger, W
    BLOOD, 2000, 96 (09) : 3102 - 3108
  • [45] Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection
    Wijburg, OLC
    DiNatale, S
    Vadolas, J
    vanRooijen, N
    Strugnell, RA
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9450 - 9457
  • [46] Successful induction therapy of natural killer/cytotoxic T-lymphocyte cells in the treatment of Langerhans' cell histiocytosis
    Hirose, M
    Kuroda, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (04) : 272 - 273
  • [47] CHOLERA-TOXIN ACTS AS A POTENT ADJUVANT FOR THE INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES WITH NONREPLICATING ANTIGENS
    BOWEN, JC
    NAIR, SK
    REDDY, R
    ROUSE, BT
    IMMUNOLOGY, 1994, 81 (03) : 338 - 342
  • [48] Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer: A Pilot Study
    Wright, Stephen E.
    Rewers-Felkins, Kathleen A.
    Quinlin, Imelda S.
    Phillips, Catherine A.
    Townsend, Mary
    Philip, Ramila
    Dobrzanski, Mark J.
    Lockwood-Cooke, Pamela R.
    Robinson, William
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (02) : 196 - 204
  • [49] THE ROLES OF CD8 IN CYTOTOXIC T-LYMPHOCYTE FUNCTION
    OROURKE, AM
    MESCHER, MF
    IMMUNOLOGY TODAY, 1993, 14 (04): : 183 - 188
  • [50] Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells
    Antje Hoff
    Ana-Cristina Bagû
    Thomas André
    Günter Roth
    Karl-Heinz Wiesmüller
    Brigitte Gückel
    Roland Brock
    Cancer Immunology, Immunotherapy, 2010, 59 : 1379 - 1387